ArticleExperimental hematology & oncology2023

Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation.

Chuntao Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.